Sex-Specific Total Testosterone and Dehydroepiandrosterone Sulfate Status in Noncritically Ill Hospitalized Patients with Coronavirus Disease 2019: A Cross-Sectional Study

    November 2023 in “ PubMed ”
    Hurjahan Banu, Md Shahed Morshed, Nusrat Sultana … Shohael Mahmud Arafat
    Studysummary This study found significant gender differences in total testosterone and dehydroepiandrosterone sulfate levels among noncritical COVID-19 patients, which were associated with severity markers in males.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pmc.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Role of Testosterone in SARS-CoV-2 Infection: A Key Pathogenic Factor and a Biomarker for Severe Pneumonia International Journal of Infectious Diseases · 2021
    2. The Double-Edged Sword of Testosterone’s Role in the COVID-19 Pandemic Frontiers in Endocrinology · 2021
    3. Molecular Mechanisms Leading to Sex-Specific COVID-19 Prognosis and Targeted Therapies Frontiers in Medicine · 2020
    4. Alert to US Physicians: DHEA, Widely Used as an OTC Androgen Supplement, May Exacerbate COVID-19 Endocrine-related Cancer · 2020